Our partner pharmacy is transitioning to a new, larger facility to better serve you
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated an average weight loss of 15% in clinical trials when combined with lifestyle modification
Learn more about the recommended injection sites for Wegovy and a step-by-step guide on how to inject Wegovy properly for the best weight loss results in combination with a low-calorie diet and physical activity
Recommended Dosage Regimen for Pediatric Patients Aged 12 Years and Older a Not approved as maintenance dosages b See Dosage Modifications for Adverse Reactions Maintenance Dosage The maintenance dosage of WEGOVY in pediatric patients aged 12 years and older is 2.4 mg once weekly
Begin with good sources to restore reduced glutathione efficiently
Current UK prescribing practice typically involves discontinuing weight loss injections before planned conception, with a focus on maintaining weight loss through lifestyle measures during the preconception period and pregnancy